Edition:
United Kingdom

Melinta Therapeutics Inc (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

2.50USD
3:40pm GMT
Change (% chg)

$-0.26 (-9.42%)
Prev Close
$2.76
Open
$2.72
Day's High
$2.72
Day's Low
$2.50
Volume
33,238
Avg. Vol
104,959
52-wk High
$18.15
52-wk Low
$2.26

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.76 December 16 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 1
(2) OUTPERFORM 4 3 3 2
(3) HOLD 2 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.12 2.12 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 18.94 21.80 14.40 2.48
Year Ending Dec-18 7 70.24 93.00 57.40 8.03
Year Ending Dec-19 7 99.83 137.80 77.30 20.00
Earnings (per share)
Quarter Ending Dec-18 5 -0.76 -0.64 -1.02 -0.95
Quarter Ending Mar-19 1 -0.54 -0.54 -0.54 --
Year Ending Dec-18 6 -3.55 -2.76 -4.19 -4.18
Year Ending Dec-19 8 -2.62 -0.90 -6.90 -4.13

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 16.58 34.08 17.50 105.54
Quarter Ending Jun-18 13.40 12.02 1.38 10.28
Quarter Ending Mar-18 12.92 14.84 1.92 14.86
Quarter Ending Dec-17 3.89 4.23 0.34 8.79
Quarter Ending Sep-17 2.22 1.72 0.51 22.80
Earnings (per share)
Quarter Ending Sep-18 -0.94 -0.40 0.54 -57.26
Quarter Ending Jun-18 -1.14 -1.38 0.24 -21.40
Quarter Ending Mar-18 -1.30 -1.53 0.23 -17.62
Quarter Ending Dec-17 -0.76 -1.48 0.72 -95.59
Quarter Ending Sep-17 -0.78 -1.00 0.22 -27.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 18.94 18.94 21.28 22.00 2.48
Year Ending Dec-18 70.24 70.24 65.24 66.09 8.03
Year Ending Dec-19 99.83 99.83 105.30 105.30 20.00
Earnings (per share)
Quarter Ending Dec-18 -0.76 -0.76 -0.74 -0.73 -0.95
Quarter Ending Mar-19 -0.54 -0.54 -0.54 -0.54 --
Year Ending Dec-18 -3.55 -3.55 -3.76 -3.74 -4.18
Year Ending Dec-19 -2.62 -2.83 -2.86 -2.86 -4.13

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 2
Year Ending Dec-18 0 0 2 1
Year Ending Dec-19 0 0 0 3
Earnings
Quarter Ending Dec-18 0 0 1 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 2 0
Year Ending Dec-19 2 0 3 0